Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Debt/Equity

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Total Debt/Equity(x) 0.190.180.180.170.33

What is the latest Total Debt/Equity ratio of NATH BIOGENES (INDIA) ?

The latest Total Debt/Equity ratio of NATH BIOGENES (INDIA) is 0.19 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.19
Mar20240.18
Mar20230.18
Mar20220.17
Mar20130.33

How is Total Debt/Equity of NATH BIOGENES (INDIA) Trending?

Years Total Debt/Equity % Change
Mar2025 0.19
5.56
Mar2024 0.18
0.00
Mar2023 0.18
5.88
Mar2022 0.17
-48.48
Mar2013 0.33 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Total Debt/Equity ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹310.9 Cr -1.8% -3.1% -8.5% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹14,114.2 Cr -3.3% -3.3% -33% Stock Analytics
KAVERI SEED COMPANY ₹5,474.2 Cr 9.8% 0.9% 16.2% Stock Analytics
VENKYS (INDIA) ₹1,884.7 Cr 1.3% -7.7% -22.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,193.6 Cr -3.6% -6% -26.6% Stock Analytics
INDO US BIOTECH ₹249.4 Cr -5.7% -4.3% -47.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1.8%

-3.1%

-8.5%

SENSEX

1%

2.5%

6.5%


You may also like the below Video Courses